Kokuvi Atsou

The Chikungunya Epidemic on La Réunion Island in 2005–2006: A Cost-of-Illness Study

Man-Koumba Soumahoro, Pierre‐Yves Boëlle, Bernard-Alex Gaüzère et al. · PLoS neglected tropical diseases · 2011 · 138 citations · Full text

Pharmacy, Health Sciences, Pharmacoeconomics +17

Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection.

Sylvie Deuffic‐Burban, Kokuvi Atsou, N. Viget et al. · PubMed · 2010 · 54 citations

Pharmacy, Pharmacoeconomics, Preventive Medicine +15

Simulation-Based Estimates of Effectiveness and Cost-Effectiveness of Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease

Kokuvi Atsou, C. Chouaïd, Gilles Hejblum · PLoS ONE · 2011 · 41 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +12

Cost-Benefit Analysis of a Simulated Institution-Based Preoperative Smoking Cessation Intervention in Patients Undergoing Total Hip and Knee Arthroplasties in France

Gilles Hejblum, Kokuvi Atsou, Bertrand Dautzenberg et al. · CHEST Journal · 2008 · 32 citations

Pharmacy, Orthopaedic Surgery, Orthopedic Surgery +12

Cost-Effectiveness of Cemiplimab Versus Standard of Care in the United States for First-Line Treatment of Advanced Non-small Cell Lung Cancer With Programmed Death-Ligand 1 Expression ≥50%

Andreas Kuznik, Caitlin Smare, Chieh-I Chen et al. · Value in Health · 2021 · 32 citations

Pharmacy, Oncology, Pharmacoeconomics +17